The collaboration aims to develop differentiated biologics that offer greater convenience and accessibility for patients
The early-stage study will test the drug’s safety, tolerability and biological effects in humans
AbbVie receives the option to license worldwide rights to CUG252 from Cugene, a clinical-stage and potential best-in-class Treg-selective IL-2 mutein, building on AbbVie's commitment to developing novel therapies in immunology
Initiative seeks innovative experimental and computational approaches to uncover neural circuits regulating immune function and identify novel therapeutic targets
Exclusive Asia-Pacific licensing agreement for Bejescin strengthens the company’s nephrology and autoimmune disease portfolio
The deal also establishes a new subsidiary, Excellos Labs, which will oversee continued operations in San Diego
The initiative by Rheumatology Association of Gujarat is aimed at strengthening patient-centric autoimmune care
The six-part webinar series aims to enhance awareness, diagnosis, and management of autoimmune diseases
Patients, doctors, and caregivers come together to promote awareness, early intervention, and pain-free living
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
